Understanding flucloxacillin prescribing trends and treatment non-response in UK primary care: a Clinical Practice Research Datalink (CPRD) study
Understanding flucloxacillin prescribing trends and treatment non-response in UK primary care: a Clinical Practice Research Datalink (CPRD) study
Objectives The volume of prescribed antibiotics is associated with antimicrobial resistance and, unlike most other antibiotic classes, flucloxacillin prescribing has increased. We aimed to describe UK primary care flucloxacillin prescribing and factors associated with subsequent antibiotic prescribing as a proxy for non-response.
Patients and methods Clinical Practice Research Datalink patients with acute prescriptions for oral flucloxacillin between January 2004 and December 2013, prescription details, associated Read codes and patient demographics were identified. Monthly prescribing rates were plotted and logistic regression identified factors associated with having a subsequent antibiotic prescription within 28 days.
Results 3 031 179 acute prescriptions for 1 667 431 patients were included. Average monthly prescription rates increased from 4.74 prescriptions per 1000 patient-months in 2004 to 5.74 (increase of 21.1 in 2013. The highest prescribing rates and the largest increases in rates were seen in older adults (70+ years), but the overall increase in prescribing was not accounted for by an ageing population. Prescribing 500 mg tablets/capsules rather than 250 mg became more common. Children were frequently prescribed low doses and small volumes (5 day course) and prescribing declined for children, including for impetigo. Only 4.2% of new prescriptions involved co-prescription of another antibiotic. Age (<5 and ≥60 years), diagnosis of ‘cellulitis or abscess’ or no associated code, and 500 mg dose were associated with a subsequent antibiotic prescription, which occurred after 17.6% of first prescriptions.
Conclusions
There is a need to understand better the reasons for increased prescribing of flucloxacillin in primary care, optimal dosing (and the need to co-prescribe other antibiotics) and the reasons why one in five patients are prescribed a further antibiotic within 4 weeks.
2037-2046
Francis, Nicholas
9b610883-605c-4fee-871d-defaa86ccf8e
Hood, Kerenza
af7cf839-ca85-4ea9-83c3-3dd31be88b32
Lyons, Ronan
7e2b5912-18d1-4019-8091-5c9fc98f1a12
Butler, Christopher Collett
d2f9102c-54c2-4570-be4e-32324c8c8f1d
18 April 2016
Francis, Nicholas
9b610883-605c-4fee-871d-defaa86ccf8e
Hood, Kerenza
af7cf839-ca85-4ea9-83c3-3dd31be88b32
Lyons, Ronan
7e2b5912-18d1-4019-8091-5c9fc98f1a12
Butler, Christopher Collett
d2f9102c-54c2-4570-be4e-32324c8c8f1d
Francis, Nicholas, Hood, Kerenza, Lyons, Ronan and Butler, Christopher Collett
(2016)
Understanding flucloxacillin prescribing trends and treatment non-response in UK primary care: a Clinical Practice Research Datalink (CPRD) study.
Journal of Antimicrobial Chemotherapy, 71 (7), .
(doi:10.1093/jac/dkw084).
Abstract
Objectives The volume of prescribed antibiotics is associated with antimicrobial resistance and, unlike most other antibiotic classes, flucloxacillin prescribing has increased. We aimed to describe UK primary care flucloxacillin prescribing and factors associated with subsequent antibiotic prescribing as a proxy for non-response.
Patients and methods Clinical Practice Research Datalink patients with acute prescriptions for oral flucloxacillin between January 2004 and December 2013, prescription details, associated Read codes and patient demographics were identified. Monthly prescribing rates were plotted and logistic regression identified factors associated with having a subsequent antibiotic prescription within 28 days.
Results 3 031 179 acute prescriptions for 1 667 431 patients were included. Average monthly prescription rates increased from 4.74 prescriptions per 1000 patient-months in 2004 to 5.74 (increase of 21.1 in 2013. The highest prescribing rates and the largest increases in rates were seen in older adults (70+ years), but the overall increase in prescribing was not accounted for by an ageing population. Prescribing 500 mg tablets/capsules rather than 250 mg became more common. Children were frequently prescribed low doses and small volumes (5 day course) and prescribing declined for children, including for impetigo. Only 4.2% of new prescriptions involved co-prescription of another antibiotic. Age (<5 and ≥60 years), diagnosis of ‘cellulitis or abscess’ or no associated code, and 500 mg dose were associated with a subsequent antibiotic prescription, which occurred after 17.6% of first prescriptions.
Conclusions
There is a need to understand better the reasons for increased prescribing of flucloxacillin in primary care, optimal dosing (and the need to co-prescribe other antibiotics) and the reasons why one in five patients are prescribed a further antibiotic within 4 weeks.
This record has no associated files available for download.
More information
Accepted/In Press date: 23 February 2016
Published date: 18 April 2016
Identifiers
Local EPrints ID: 436083
URI: http://eprints.soton.ac.uk/id/eprint/436083
ISSN: 0305-7453
PURE UUID: 08391fe0-300b-4f18-9556-a1a07c4c927d
Catalogue record
Date deposited: 27 Nov 2019 17:30
Last modified: 17 Mar 2024 03:58
Export record
Altmetrics
Contributors
Author:
Kerenza Hood
Author:
Ronan Lyons
Author:
Christopher Collett Butler
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics